title: Minimal Transplant Survival Benefit for Hepatocellular Carcinoma: Is it Real or an Overestimation of Waitlist Life Expectancy?
authors.affiliation: Division of Gastroenterology, Department of Medicine, University of California San Francisco, San Francisco, California.
authors.forename: Neil
authors.initials: N
authors.lastname: Mehta
authors.affiliation: Division of Transplantation, Department of Surgery, Mayo Clinic, Rochester, Minnesota.
authors.forename: Julie
authors.initials: J
authors.lastname: Heimbach
authors.affiliation: Division of Transplant Surgery, Department of Surgery, University of California San Francisco, San Francisco, California.
authors.forename: Ryutaro
authors.initials: R
authors.lastname: Hirose
authors.affiliation: Division of Transplant Surgery, Department of Surgery, University of California San Francisco, San Francisco, California.
authors.forename: John P
authors.initials: JP
authors.lastname: Roberts
authors.affiliation: Division of Gastroenterology, Department of Medicine, and Division of Transplant Surgery, Department of Surgery, University of California, San Francisco, San Francisco, California.
authors.forename: Francis Y
authors.initials: FY
authors.lastname: Yao
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000601:surgery*; D003661:Decision Support Techniques; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000601:surgery*; D016031:Liver Transplantation; D008297:Male